Zhang L - Search Results

1

Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine.

Chen X, Zhang L, Ren S, Li X, Zhou F, Li W, Gao G, He Y, Zhou C. Chen X, et al. Among authors: zhang l. Med Oncol. 2014 Apr;31(4):865. doi: 10.1007/s12032-014-0865-z. Epub 2014 Feb 18. Med Oncol. 2014. PMID: 24535606

2

[Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].

Zhou SW, Ren SX, Yan LH, Zhang L, Zhou CC. Zhou SW, et al. Among authors: zhang l. Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):469-72. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024526 Chinese.

3

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer.

Zhou S, Ren S, Yan L, Zhang L, Tang L, Zhang J, Zhou C. Zhou S, et al. Among authors: zhang l, zhang j. Respirology. 2009 Jul;14(5):709-15. doi: 10.1111/j.1440-1843.2009.01564.x. Respirology. 2009. PMID: 19659649 Clinical Trial.

4

BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.

Li Z, Zhou S, Zhang L, Su C, Hang J, Zhao Y, Su B, Zhou C. Li Z, et al. Among authors: zhang l. Med Oncol. 2011 Jun;28(2):572-7. doi: 10.1007/s12032-010-9470-y. Epub 2010 Mar 17. Med Oncol. 2011. PMID: 20237869

5

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J. Zhou C, et al. Among authors: zhang l, zhang z, zhang j. Jpn J Clin Oncol. 2010 Oct;40(10):954-60. doi: 10.1093/jjco/hyq071. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462983

6

ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.

Su C, Zhou S, Zhang L, Ren S, Xu J, Zhang J, Lv M, Zhang J, Zhou C. Su C, et al. Among authors: zhang l, zhang j. Med Oncol. 2011 Dec;28(4):1411-7. doi: 10.1007/s12032-010-9553-9. Epub 2010 May 14. Med Oncol. 2011. PMID: 20467918

7

High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

Ren S, Zhou S, Zhang L, Xu J, Lv M, Zhang J, Zhou C, Zhang J. Ren S, et al. Among authors: zhang l, zhang j. Cancer Invest. 2010 Dec;28(10):1078-83. doi: 10.3109/07357901003735659. Epub 2010 May 26. Cancer Invest. 2010. PMID: 20504223 Clinical Trial.

8

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, Xu J, Lv M, Zhang J, Zhou C. Ren S, et al. Among authors: zhang l, zhang j. Lung Cancer. 2012 Jan;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023. Epub 2011 Jun 14. Lung Cancer. 2012. PMID: 21676483

9

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Chen X, Sun H, Ren S, Kim Curran V, Zhang L, Zhou S, Zhang J, Zhou C. Chen X, et al. Among authors: zhang l, zhang j. Clin Transl Oncol. 2012 Mar;14(3):207-13. doi: 10.1007/s12094-012-0785-3. Clin Transl Oncol. 2012. PMID: 22374424

10

Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy.

Zhang L, Gao G, Li X, Ren S, Li A, Xu J, Zhang J, Zhou C. Zhang L, et al. Among authors: zhang j. PLoS One. 2012;7(10):e48350. doi: 10.1371/journal.pone.0048350. Epub 2012 Oct 31. PLoS One. 2012. PMID: 23118991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,373 results

Search Page

Filters